Literature DB >> 3943117

New approaches to antitumor drug screening: the human tumor colony-forming assay.

R H Shoemaker.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3943117

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN： 0361-5960


× No keyword cloud information.
  8 in total

Review 1.  Is the P388 murine tumor no longer adequate as a drug discovery model?

Authors:  T H Corbett; F A Valeriote; L H Baker
Journal:  Invest New Drugs       Date:  1987       Impact factor: 3.850

2.  The colony inhibition of a new chemotherapeutic agent (KW2152) against human lung cancer cell lines.

Authors:  J R Jett; N Saijo; W S Hong; Y Sasaki; H Takahashi; H Nakano; K Nakagawa; M Sakurai; K Suemasu; M Tesada
Journal:  Invest New Drugs       Date:  1987       Impact factor: 3.850

Review 3.  Tumor models in drug development.

Authors:  D P Griswold; S D Harrison
Journal:  Cancer Metastasis Rev       Date:  1991-10       Impact factor: 9.264

Review 4.  Chloroquinoxaline sulfonamide: a sulfanilamide antitumor agent entering clinical trials.

Authors:  J S Fisherman; B L Osborn; H G Chun; J Plowman; A C Smith; M C Christian; D S Zaharko; R H Shoemaker
Journal:  Invest New Drugs       Date:  1993-02       Impact factor: 3.850

5.  Cytotoxic activity of the thioether phospholipid analogue BM 41.440 in primary human tumor cultures.

Authors:  D B Herrmann; H A Neumann
Journal:  Lipids       Date:  1987-11       Impact factor: 1.880

6.  In vitro antitumor effect of recombinant human tumor necrotizing factor on cultured human cancer cell lines and freshly isolated lung cancer cells by the human tumor clonogenic assay.

Authors:  Y Sasaki; F Kanzawa; H Takahashi; Y Matsushima; H Nakano; K Nakagawa; W S Hong; K Minato; Y Fujiwara; N Saijo
Journal:  Invest New Drugs       Date:  1987-12       Impact factor: 3.850

7.  Evaluation of in vitro drug screening leads using experimental models of human ovarian cancer.

Authors:  K G Louie; T C Hamilton; R H Shoemaker; R C Young; R F Ozols
Journal:  Invest New Drugs       Date:  1992-07       Impact factor: 3.850

8.  Clinical and pharmacology study of chloroquinoxaline sulfonamide given on a weekly schedule.

Authors:  J R Rigas; P A Francis; V A Miller; W P Tong; N Roistacher; M G Kris; J P Orazem; C W Young; R P Warrell
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.